An in vivo proton magnetic resonance spectroscopy study with optimized echo-time technique for concurrent
Chi-Hyeon Yoo1,2,3, Hyeon-Man Baek2, Kyu-Ho Song4
1Department of Biomedicine and Health Sciences, Research Institute of Biomedical Engineering, College of Medicine, The Catholic University of Korea, #222 Banpo-Daero Seocho-Gu, Seoul, 06591, Republic of Korea.
Objective:
The present study applied in vivo proton magnetic resonance spectroscopy (1H MRS) to concurrently measure the concentration and T2 relaxation time of glutamate with the concept of optimized-for-quantification-and-T2-measurement-of-glutamate (OpQT2-Glu).
Materials And Methods:
7T MRS scans of the OpQT2-Glu were acquired from the prefrontal cortex of five rats. The echo-time-(TE)-specific J-modulation of glutamate was investigated by spectral simulations and analyses for selecting the eight TEs appropriate for T2 estimation of glutamate. The OpQT2-Glu results were compared to those of the typical short-TE MRS and T2 measurements.
Results:
No significant differences were observed between the OpQT2-Glu and typical short-TE MRS (p > 0.050). The estimated glutamate T2 (67.75 ms) of the OpQT2-Glu was similar to the multiple TE MRS for the T2 measurement (71.58 ms) with enhanced signal-to-noise ratio and reliability.
Discussion:
The results revealed that the quantification reliability of the OpQT2-Glu was comparable to that of the single short-TE MRS and its estimation reliability for the T2 relaxation time of glutamate was enhanced compared to the multiple TE MRS for T2 measurement. Despite certain limitations, the quantification and T2 estimation of glutamate can be concurrently performed within an acceptable scan time via high-field in vivo 1H MRS with the OpQT2-Glu.
